Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7327 p778
27 November 2004

This article
Reprint   Photocopy

  Acrobat Reader


News summary


NSAIDs of limited benefit in osteoarthritis

Non-steroidal anti-inflammatory drugs (NSAIDs) are only slightly better than placebo at reducing the pain of knee osteoarthritis over the short term.

This is the conclusion of researchers from Norway who analysed 23 trials involving 10,845 patients. The researchers point out that current guidelines recommend the use of oral NSAIDs as second-line therapy, after paracetamol, in the treatment of knee osteoarthritis. However, they say that NSAIDs are used regularly by half of all patients with this condition.

The current research reveals that the advantage of oral NSAIDs over placebo for short-term pain relief is small — using a visual analogue scale, the pooled difference for pain was 10.1mm (95 per cent confidence interval 7.4 to 12.8) or 15.6 per cent better than placebo after two to 13 weeks. Earlier research suggests that pain associated with knee osteoarthritris needs to be reduced by 17 to 22 per cent to be considered meaningful.

“As use of oral NSAIDs may incur serious adverse effects, they can only be recommended for limited use in osteoarthritis of the knee,” the researchers conclude (published on BMJ Online First).

Acupuncture Using acupuncture in addition to diclofenac to treat osteoarthritis of the knee reduces pain and stiffness more than drug treatment alone. Researchers compared use of acupuncture with a placebo technique in 88 patients who all received diclofenac (50mg every eight hours). After 12 weeks patients who received acupuncture had improved pain, stiffness and physical function (BMJ 2004;329:1216).

Back to Top


©The Pharmaceutical Journal